Advertisement

Ads Placeholder
Loading...

Broncus Holding Corporation

2216.HKHKSE
Healthcare
Medical - Devices
HK$1.37
HK$-0.10(-6.80%)
Hong Kong Market is Open • 11:04

Broncus Holding Corporation Fundamental Analysis

Broncus Holding Corporation (2216.HK) shows weak financial fundamentals with a PE ratio of -5.56, profit margin of -2.49%, and ROE of -9.19%. The company generates $0.0B in annual revenue with weak year-over-year growth of -20.71%.

Key Strengths

Cash Position19.78%
PEG Ratio-136.32
Current Ratio26.99

Areas of Concern

ROE-9.19%
Operating Margin-3.34%
We analyze 2216.HK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -186.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-186.9/100

We analyze 2216.HK's fundamental strength across five key dimensions:

Efficiency Score

Weak

2216.HK struggles to generate sufficient returns from assets.

ROA > 10%
-9.15%

Valuation Score

Excellent

2216.HK trades at attractive valuation levels.

PE < 25
-5.56
PEG Ratio < 2
-136.32

Growth Score

Moderate

2216.HK shows steady but slowing expansion.

Revenue Growth > 5%
-20.71%
EPS Growth > 10%
45.57%

Financial Health Score

Excellent

2216.HK maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
26.99

Profitability Score

Weak

2216.HK struggles to sustain strong margins.

ROE > 15%
-918.69%
Net Margin ≥ 15%
-2.49%
Positive Free Cash Flow
No

Key Financial Metrics

Is 2216.HK Expensive or Cheap?

P/E Ratio

2216.HK trades at -5.56 times earnings. This suggests potential undervaluation.

-5.56

PEG Ratio

When adjusting for growth, 2216.HK's PEG of -136.32 indicates potential undervaluation.

-136.32

Price to Book

The market values Broncus Holding Corporation at 0.52 times its book value. This may indicate undervaluation.

0.52

EV/EBITDA

Enterprise value stands at -5.72 times EBITDA. This is generally considered low.

-5.72

How Well Does 2216.HK Make Money?

Net Profit Margin

For every $100 in sales, Broncus Holding Corporation keeps $-2.49 as profit after all expenses.

-2.49%

Operating Margin

Core operations generate -3.34 in profit for every $100 in revenue, before interest and taxes.

-3.34%

ROE

Management delivers $-9.19 in profit for every $100 of shareholder equity.

-9.19%

ROA

Broncus Holding Corporation generates $-9.15 in profit for every $100 in assets, demonstrating efficient asset deployment.

-9.15%

Following the Money - Real Cash Generation

Operating Cash Flow

Broncus Holding Corporation generates limited operating cash flow of $-6.46M, signaling weaker underlying cash strength.

$-6.46M

Free Cash Flow

Broncus Holding Corporation generates weak or negative free cash flow of $-6.54M, restricting financial flexibility.

$-6.54M

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

2216.HK converts -6.51% of its market value into free cash.

-6.51%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.56

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-136.32

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.52

vs 25 benchmark

P/S Ratio

Price to sales ratio

15.14

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

26.99

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.09

vs 25 benchmark

ROA

Return on assets percentage

-0.09

vs 25 benchmark

ROCE

Return on capital employed

-0.13

vs 25 benchmark

How 2216.HK Stacks Against Its Sector Peers

Metric2216.HK ValueSector AveragePerformance
P/E Ratio-5.5628.54 Better (Cheaper)
ROE-9.19%738.00% Weak
Net Margin-249.25%-43982.00% (disorted) Weak
Debt/Equity0.000.34 Strong (Low Leverage)
Current Ratio26.992806.01 Strong Liquidity
ROA-9.15%-14624.00% (disorted) Weak

2216.HK outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Broncus Holding Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

8.30%

Industry Style: Defensive, Growth, Innovation

Growing

EPS CAGR

49.45%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

32.00%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ